Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;84(3):1259-1266.
doi: 10.3233/JAD-210372.

Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease

Affiliations

Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease

David Silhan et al. J Alzheimers Dis. 2021.

Abstract

Background: Magnetic resonance imaging (MRI) visual scales of brain atrophy are important for differential diagnosis of dementias in routine clinical practice. Atrophy patterns in early- and late-onset Alzheimer's disease (AD) can be different according to some studies.

Objective: Our goal was to assess brain atrophy patterns in early- and late-onset AD using our recently developed simple MRI visual scales and evaluate their reliability.

Methods: We used Hippocampo-horn percentage (Hip-hop) and Parietal Atrophy Score (PAS) to compare mediotemporal and parietal atrophy on brain MRI among 4 groups: 26 patients with early-onset AD, 21 younger cognitively normal persons, 32 patients with late-onset AD, and 36 older cognitively normal persons. Two raters scored all brain MRI to assess reliability of the Hip-hop and PAS. Brain MRIs were obtained from Alzheimer's Disease Neuroimaging Initiative (ADNI) database.

Results: The patients with early-onset AD had significantly more pronounced mediotemporal and also parietal atrophy bilaterally compared to the controls (both p < 0.01). The patients with late-onset AD had significantly more pronounced only mediotemporal atrophy bilaterally compared to the controls (p < 0.000001), but parietal lobes were the same. Intra-rater and inter-rater reliability of both visual scales Hip-hop and PAS were almost perfect in all cases (weighted-kappa value ranged from 0.90 to 0.99).

Conclusion: While mediotemporal atrophy detected using Hip-hop is universal across the whole AD age spectrum, parietal atrophy detected using PAS is worth rating only in early-onset AD. Hip-hop and PAS are very reliable MRI visual scales.

Keywords: Early-onset Alzheimer’s disease; hippocampo-horn percentage; late-onset Alzheimer’s disease; mediotemporal atrophy; parietal atrophy; parietal atrophy score; reliability.

PubMed Disclaimer

Conflict of interest statement

Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-0372r3).

References

    1. Avila J, Perry G (2020) A multilevel view of the development of Alzheimer’s disease. Neuroscience 457, 283–293. - PubMed
    1. Bartos A, Gregus D, Ibrahim I, Tintera J (2019) Brain volumes and their ratios in Alzheimer's disease on magnetic resonance imaging segmented using FreeSurfer 6.0. Psychiatry Res Neuroimaging 287, 70–74. - PubMed
    1. Zach P, Bartos A, Lagutina A, Wurst Z, Gallina P, Rai T, Kieslich K, Riedlová J, Ibrahim I, Tintěra J, Mrzilkova J (2020) Easy identification of optimal coronal slice on brain magnetic resonance imaging to measure hippocampal area in Alzheimer’s disease patients. Biomed Res Int 2020, 5894021. - PMC - PubMed
    1. Jack CR Jr, Shiung MM, Gunter JL, O’Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591–600. - PMC - PubMed
    1. Fennema-Notestine C, McEvoy LK, Hagler DJ Jr, Jacobson MW, Dale AM, The Alzheimer’s Disease Neuroimaging Initiative (2009) Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. Behav Neurol 21, 3–12. - PMC - PubMed

Publication types